Calvin Sternick

Stock Analyst at JP Morgan

(2.74)
# 1,955
Out of 4,735 analysts
18
Total ratings
41.67%
Success rate
10.33%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Dec 3, 2024
Maintains: Overweight
Price Target: $117$120
Current: $90.07
Upside: +33.23%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $63.66
Upside: +25.67%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $13.96
Upside: +93.41%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $188.78
Upside: -3.59%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $134.43
Upside: -39.75%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $297.44
Upside: +31.79%